Apyx Medical Corporation focuses on the development, manufacturing, and sale of innovative medical technologies. The company primarily serves the aesthetic surgery and cosmetic markets by offering products that enhance patient outcomes. Its core business includes the use of its proprietary Helium Plasma Technology for surgical solutions, widely utilized in minimally invasive procedures.

Apyx Medical Corporation operates within the healthcare sector, specifically in the medical device and technology industry. The company's focus is on providing advanced energy-based systems for aesthetic and surgical applications, targeting healthcare providers and patients seeking innovative, safe, and effective solutions.

Apyx Medical Corporation primarily generates revenue through the sale of its proprietary products, such as the Renuvion and J-Plasma systems, which are used in cosmetic surgery and other medical procedures. The company also earns income from consumables, accessories, and after-market services associated with these devices.

Apyx Medical Corporation competes with other medical device manufacturers that serve the aesthetic and surgical markets. Key competitors include companies offering alternative energy-based solutions, such as laser or radiofrequency devices, for minimally invasive and cosmetic procedures.

Apyx Medical Corporation's growth opportunities include expanding its footprint in the global aesthetic surgery market, entering new geographic regions, and gaining regulatory approvals for broader applications of its technologies. Increasing demand for minimally invasive procedures also presents potential for further adoption of its proprietary systems.

Key risks for Apyx Medical Corporation include competition from larger players in the medical device industry, regulatory hurdles, and reliance on the success of its primary technologies. Market conditions and changes in healthcare spending could also impact the company's performance.

No, Apyx Medical Corporation does not currently pay dividends to its shareholders. The company focuses on reinvesting its income into research and development, as well as growth initiatives, to strengthen its position in the medical device industry.

Investors can review Apyx Medical Corporation’s financial statements, including revenue growth trends, profitability metrics, and cash flow. Additionally, analyzing its debt levels, research and development expenditures, and market share in the aesthetic and surgical device sector provides insights into the company's financial stability.